Pricing Log in Create free account

Anbio Biotechnology (NNNN) vs STAAR Surgical Company (STAA)

Anbio Biotechnology and STAAR Surgical Company are both Medical Instruments & Supplies companies. STAAR Surgical Company is the larger, with a market value of $1.1B against $474.8M — 2.4× the size. Across the 8 metrics below, Anbio Biotechnology leads on 5 and STAAR Surgical Company on 3.

Valuation

Metric NNNN STAA Medical Instruments & Supplies median
P/E — 303.86 33.75
P/S — 3.15 2.52
P/B n/m 2.93 2.48
Price to free cash flow n/m n/m 25.19
EV/EBITDA n/m 39.68 14.62
EV/Sales n/m 2.71 2.88
Earnings yield — 0.33% (2.67%)
Free cash flow yield 0.00% (0.64%) 0.09%

Profitability

Metric NNNN STAA Medical Instruments & Supplies median
Gross margin — 76.62% 54.29%
Operating margin — 4.04% 1.07%
Net margin — 1.13% (1.61%)
Free cash flow margin 0.00% (1.99%) 1.08%
Return on equity 0.00% 1.09% (1.32%)
Return on assets 0.00% 0.84% 0.00%
Return on invested capital 0.00% 4.67% 0.00%

Growth

Metric NNNN STAA Medical Instruments & Supplies median
Revenue growth (TTM) — 51.30% 8.85%
EPS growth (last fiscal year) 150.00% (295.12%) 8.65%
Revenue growth, 5-year CAGR — 7.93% 9.17%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric NNNN STAA Medical Instruments & Supplies median
Debt to equity 0.00 0.00 0.10
Current ratio 344.45 4.66 2.48
Net debt to EBITDA (2.06) 2.25 0.89

Dividend

Metric NNNN STAA Medical Instruments & Supplies median
Dividend yield — — 1.11%
Payout ratio — — 0.27

Size

Metric NNNN STAA Medical Instruments & Supplies median
Market cap 474.84m 1.12b 619.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack